Pharmaceutical formulation: identical 8 [{ 1-(3,5-BIS (TRIFLUOROMETHY1) PHENY1)-E THOXY }-METHY1] -8-PHENY1-1,7- diazas-breathing [4. are used5] salt of decan -2- one and treatment measures
Pharmaceutical formulations containing salts of (5S,8S)-8-[{(1 R)-1-(3,5-Bis-trifluoromethyl)phenyl]-ethoxy}-methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one, represented by Formula I, are disclosed. Disclosed also are methods of treatment utilizing such dosage forms.Farmasøytiske preparater som inneholder salter av (5S,8S)-8-[ { (1R)-1-(3,5-bis-trifluormetyl)fenyl]-etoksy}metyl]-8-fenyl-l,7-diazaspiro[4.5]dekan-2-on, representert ved formel I, beskrives. Videre beskrives fremgangsmåter for behandling ved benyttelse av slike doseringsformer.